These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Two cases of Graves' disease with anti-thyroid hormone autoantibodies: the effect of subtotal thyroidectomy on the titers of anti-thyroid hormone autoantibodies and anti-Tg antibodies]. Nagai K; Maekawa H; Kametani M; Tokimitsu N; Komaki T; Kojima N; Sakata S Nihon Naibunpi Gakkai Zasshi; 1989 Nov; 65(11):1219-25. PubMed ID: 2591608 [TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone autoantibodies in patients with Graves' disease: effect of anti-thyroid drug treatment. Ogawa T; Sakata S; Nakamura S; Takuno H; Matsui I; Sarui H; Yasuda K Clin Chim Acta; 1994 Aug; 228(2):113-22. PubMed ID: 7988028 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of thyroid function in patients with thyroid hormone autoantibodies. Sakata S; Komaki T; Ogawa T; Takuno H; Matsui I; Sarui H; Kojima N; Takamatsu J; Miura K Clin Chim Acta; 1993 Oct; 219(1-2):23-34. PubMed ID: 8306461 [TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes and thyroid-stimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves' disease. van der Heide D; Daha MR; Bolk JH; Bussemaker JK; de Bruin TW; Goslings BM; van Es LA; Querido A Lancet; 1980 Jun; 1(8183):1376-9. PubMed ID: 6155582 [TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone autoantibodies in primary Sjögren syndrome and rheumatoid arthritis are more prevalent than in autoimmune thyroid disease, becoming progressively more frequent in these diseases. Ruggeri RM; Galletti M; Mandolfino MG; Aragona P; Bartolone S; Giorgianni G; Alesci D; Trimarchi F; Benvenga S J Endocrinol Invest; 2002 May; 25(5):447-54. PubMed ID: 12035942 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of circulating thyroid hormone autoantibodies in thyroid diseases, in autoimmune non thyroid illnesses and in lymphoreticular system disorders. Trimarchi F; Benvenga S; Costante G; Barbera C; Melluso R; Marcocci C; Chiovato L; De Luca F; Consolo F J Endocrinol Invest; 1983 Jun; 6(3):203-9. PubMed ID: 6688626 [No Abstract] [Full Text] [Related]
8. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [TBL] [Abstract][Full Text] [Related]
10. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease. Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563 [TBL] [Abstract][Full Text] [Related]
11. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis. Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460 [TBL] [Abstract][Full Text] [Related]
12. The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease. Cho SW; Bae JH; Noh GW; Kim YA; Moon MK; Park KU; Song J; Yi KH; Park do J; Chung JK; Cho BY; Park YJ PLoS One; 2015; 10(12):e0144599. PubMed ID: 26650844 [TBL] [Abstract][Full Text] [Related]
13. Incidence of T cell subset imbalance in relatives of Graves' disease patients. Biassoni P; Ciprandi G; Ferrini S; Chimini G; Canonica GW; Bagnasco M J Endocrinol Invest; 1984 Apr; 7(2):141-5. PubMed ID: 6609952 [TBL] [Abstract][Full Text] [Related]
14. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336 [TBL] [Abstract][Full Text] [Related]
16. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy. Molnár I; Balázs C Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853 [TBL] [Abstract][Full Text] [Related]
18. Changes in serum thyroid hormone autoantibody concentrations during pregnancy: a case report. Abs R; Martin M; Blockx P Horm Res; 1991; 35(5):205-7. PubMed ID: 1802824 [TBL] [Abstract][Full Text] [Related]
19. Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease. Lamberg BA; Aro A; Saarinen P; Tötterman T; Mäkinen T J Endocrinol Invest; 1978 Jan; 1(1):9-16. PubMed ID: 90688 [No Abstract] [Full Text] [Related]
20. Autoantibodies against thyroid hormones or iodothyronine. Implications in diagnosis, thyroid function, treatment, and pathogenesis. Sakata S; Nakamura S; Miura K Ann Intern Med; 1985 Oct; 103(4):579-89. PubMed ID: 3898955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]